ahlam1399
09-22-2015, 12:12 PM
BRIEF-Galapagos presents pre-clinical and phase 1 results with autotaxin inhibitor GLPG1690
* Presents promising pre-clinical and phase 1 results with autotaxin inhibitor GLPG1690 at the European Respiratory Society (ERS) Annual Meeting in Amsterdam, Netherlands
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a0dad8f/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=nARMil3Wwnc:XxtfaZ9QOLQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=nARMil3Wwnc:XxtfaZ9QOLQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=nARMil3Wwnc:XxtfaZ9QOLQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=nARMil3Wwnc:XxtfaZ9QOLQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=nARMil3Wwnc:XxtfaZ9QOLQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/nARMil3Wwnc
* Presents promising pre-clinical and phase 1 results with autotaxin inhibitor GLPG1690 at the European Respiratory Society (ERS) Annual Meeting in Amsterdam, Netherlands
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4a0dad8f/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=nARMil3Wwnc:XxtfaZ9QOLQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=nARMil3Wwnc:XxtfaZ9QOLQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=nARMil3Wwnc:XxtfaZ9QOLQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=nARMil3Wwnc:XxtfaZ9QOLQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=nARMil3Wwnc:XxtfaZ9QOLQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/nARMil3Wwnc